Pixyl receives FDA approval for AI brain MRI software

The US Food and Drug Administration (FDA) has approved Pixyl’s AI brain MRI analysis software, Pixyl.Neuro.

The software increases detection rates by up to 28%, according to the company. It quantifies and compares MRI findings to identify abnormal atrophy earlier and aid diagnosis, the company said.

Facilities in more than a dozen countries in Europe, North America and Africa use Pixyl.Neuro, Pixyl said.

READ MORE  The Best Enterprise Resource Planning Software Organizations Need in 2023, Revealed by SoftwareReviews

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button